NCT02532361

Proportion of Hysterectomy After Female Sterilization

A Retrospective Analysis to Describe the Proportion of Hysterectomy After Female Sterilization With Hysteroscopic Device or Tubal Ligation Using Intermountain Healthcare Database in the US

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 10,578 (actual)
• Sponsor: Bayer · Industry
• Sex: Female
• Age: 18 Years – 49 Years
• Healthy volunteers: Not accepted

Summary

The objective of this study is to describe the proportion of hysterectomy in patients that had undergone sterilization through hysteroscopic device placement and the patients that had undergone sterilization through tubal ligation.

Conditions

• Hysterectomy

Interventions

Type	Name	Description
DEVICE	Hysteroscopic device placement including Essure (ESS305, BAY1454032)	Essure is a permanent, minimally invasive, non-hormonal implantable device used for contraception and Adiana sterilization method is a combination of controlled thermal damage to the lining of the fallopian tube followed by insertion of a non-absorbable biocompatible silicone elastomer matrix within the tubal lumen
PROCEDURE	Tubal ligation	Tubal ligation or tubectomy is a surgical procedure for sterilization in which a woman's fallopian tubes are clamped and blocked, or severed and sealed, either method of which prevents eggs from reaching the uterus for implantation

Timeline

• Start date: 2015-08-01
• Primary completion: 2015-12-01
• Completion: 2015-12-01
• First posted: 2015-08-25
• Last updated: 2016-12-23

Locations

1 site across 1 country: United States